Expect significant downward pressure on the stock due to imminent dilution. Monitor for conversion notices and any further financing announcements. The note terms likely allow conversion at a deep discount, exacerbating share count expansion.
Price Chart
Executive Summary
Clearmind Medicine announced the issuance of $600,000 in convertible promissory notes at a 10% discount (net proceeds $540,000), following an April 30 amendment to existing securities purchase agreements. For a company with a ~$1M market cap and only 158,076 shares outstanding, this represents massive potential dilution and signals acute cash needs.
Key Facts
- Aggregate principal amount of convertible promissory notes: $600,000.
- Purchase price at 90% of principal: $540,000 cash.
- Transaction expected to close May 19, 2026.
- Company had 158,076 common shares outstanding as of January 19, 2026.
- Market capitalization approximately $1 million at filing.
Financial Impact
Proceeds of $540,000 represent ~54% of current market cap. Conversion could more than double outstanding shares at a discount.
Risk Factors
- Severe equity dilution from note conversion.
- Potential going concern if cash burn continues without further funding.
- Low liquidity and tiny market cap amplify volatility.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-058428 |
| Document: 0001213900-26-058428-index-headers.html | 0001213900-26-058428 |
| Document: 0001213900-26-058428-index.html | 0001213900-26-058428 |
| Document: 0001213900-26-058428.txt | 0001213900-26-058428 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 10d ago | 6-K | $6.00 | awaiting T+60 | — | $5.87 (+2.17%) |
Oct 13, 2026 13d ago | 6-K | $6.23 | awaiting T+60 | — | $5.87 (−5.78%) |
Oct 8, 2026 18d ago | 6-K | $6.60 | awaiting T+60 | — | $5.87 (−11.06%) |
Oct 7, 2026 19d ago | 6-K | $6.60 | awaiting T+60 | — | $5.87 (−11.06%) |
Sep 23, 2026 4w ago | 6-K | $0.8500 | awaiting T+60 | — | $5.87 (+590.59%) |
Sep 23, 2026 4w ago | Press Release | $0.8500 | awaiting T+60 | — | $5.87 (+590.59%) |
Sep 17, 2026 5w ago | Press Release | $6.86 | awaiting T+60 | — | $5.87 (−14.48%) |
Sep 14, 2026 6w ago | 6-K | $0.9440 | awaiting T+60 | — | $5.87 (+521.82%) |
Sep 8, 2026 6w ago | 6-K | $1.03 | awaiting T+60 | — | $5.87 (+469.90%) |
Sep 4, 2026 7w ago | 6-K | $1.16 | awaiting T+60 | — | $5.87 (−406.03%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers